[ad_1]
Notes to the editor
Authors: ESC Press Office
Tel: +33 (0) 4 89 87 20 85
Mobile: +33 (0) 7 8531 2036
Email: [email protected]
Follow us on Twitter @ESCardioNews
Financing: This work was supported by grants from the Korean Health Technology Research and Development Project funded by the Ministry of Health and Welfare (HI15C1200, HC19C0130), Yonsei University College of Medicine (CMB-Yuhan Fellowship 6-2019-0124), and a research grant from the Fundamental Technology Development Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (MSIP) (NRF-2017M3A9E8029724).
Disclosures: BJ has been a speaker for Bayer, BMS / Pfizer, Medtronic and Daiichi-Sankyo and has received research funding from Medtronic and Abbott. All other authors declare no competing interests. No personal commissions were received.
References
1Lim C, Kim TH, Yu HT, et al. Effect of Alcohol Consumption on Adverse Event Risk in Atrial Fibrillation: From the COmparison Study of Atrial Fibrillation Registry Complications and Symptom Control Drugs (CODE-AF) Europace. 2020. doi: 10.1093 / europace / euaa340.
2The risk of stroke was calculated using the CHA2DS2-VASc score which assigns points to congestive heart failure (1), hypertension (1), age 75 years and older (2), diabetes mellitus (1), history of stroke (2), vascular disease (1), age 65-74 years (1) and gender category (female) (1). Patients are considered low-risk for stroke when the score is 0 in men and 1 in women.
Information on the European Society of Cardiology
The ESC brings together healthcare professionals from over 150 countries, who work to advance cardiovascular medicine and help people live longer, healthier lives.
About EP Europace
EP Europace covers the fields of arrhythmias, stimulation and cellular electrophysiology.
[ad_2]
Source link
